About
Oxidase enzyme chemistry
Areas of Focus
Categories
Small Molecule PharmaceuticalAustralia
Clinical Trials (35)
View allTotal Trials
35
As Lead Sponsor
31
As Collaborator
4
Total Enrollment
3,093
By Phase
PHASE2: 13PHASE1/PHASE2: 5PHASE1: 4NA: 2EARLY_PHASE1: 2PHASE3: 6
By Status
COMPLETED: 30WITHDRAWN: 3ACTIVE_NOT_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline35 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05904717Lead Sponsor
Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder
PHASE2Active, not recruiting
40 participants
Started: Nov 8, 2023 · Completed: Jan 31, 2026
NCT04676529Lead Sponsor
Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis
PHASE1/PHASE2Completed
43 participants
Started: Feb 18, 2021 · Completed: Jul 9, 2025
NCT04183517Lead Sponsor
A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males
PHASE1Completed
18 participants
Started: Dec 20, 2019 · Completed: Jun 24, 2020
NCT03620422Collaborator
Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma
NACompleted
40 participants
Started: Jan 11, 2019 · Completed: Jan 31, 2020
NCT02306473Collaborator
The Leaky Lung Test
EARLY_PHASE1Completed
100 participants
Started: Oct 31, 2015 · Completed: Dec 1, 2017
Locations (1)
Headquarters
Frenchs Forest, Australia
Map
Loading map...